The Board and management of Abano Healthcare Group have progressed a detailed review of the business, given the impact of COVID-19. With the impact of COVID 19 on Abano’s revenue since mid-March, and the likely closure of practices into May 2020, Abano’s Underlying EBITDA for FY20 is now expected to be approximately $17m (pre-IFRS 16). […]